Fear of visual loss in patients with diabetes: results of the prevalence of diabetic eye disease in Tayside, Scotland (P-DETS) study (scientific article published in October 2007)

Q38115020	Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy?
Q38865568	Diabetic brain or retina? Visual psychophysical performance in diabetic patients in relation to GABA levels in occipital cortex
Q37828638	Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review.
Q46341499	Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
Q37776148	Effect of systemic medications on onset and progression of diabetic retinopathy
Q35003495	Effects of physical activity on the development and progression of microvascular complications in type 1 diabetes: retrospective analysis of the DCCT study
Q39544664	Functional and structural change in diabetic eyes. Interim results from an ongoing longitudinal prospective study
Q36691521	Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice
Q33812061	Prevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: a 6-year follow up study.
Q39839302	Risk factors for diabetic retinopathy in a South Indian Type 2 diabetic population--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4.
Q37875909	Social and emotional impact of diabetic retinopathy: a review

P356	DOI	10.1111/J.1464-5491.2007.02180.X
P698	PubMed publication ID	17888131